Company Info
Phone(617) 870-3363
Year Established
2019
Contacts
Wendy Robbins, MDPresident & CEO
Joseph Paul Eder, MD
CMO
Thomas Schurpf, PhD
VP, Head of Development
Erin McDonald
Director of Operations
Company Description
Incendia Therapeutics, formerly Parthenon, is inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME).